The Costs of Export Controls

If there is a key word in the United States in the late 1980s, it is "competitiveness." It's a word that's used in many contexts to mean many things. In his new book The Technical Enterprise (Ballinger, 1986) Herbert Fusfeld discusses how social, economic and political pressures like the drive for competitiveness are at work in shaping the technical system today. In this adaptation from the book, he describes the practice of using export controls to keep technological advances from potential adv

Written byHerbert Fusfeld
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

There is little quarrel with the intent of export controls. Common sense indicates that no great social or intellectual purpose is served by shipping a device for undersea detection of submarines or a laser-guidance system for missiles to the Soviet Union. Those are the easy decisions. The issues quickly become more complex when the question is one of selling landing systems for Soviet airports that embody advanced memory chips available in Europe, exchanging technical data between American and Soviet metallurgists, or (as recently happened) refusing permission for technical personnel from NATO countries to attend a professional meeting on advanced optical systems.

Any restriction on linkages within the technical enterprise weakens the effectiveness of the overall system. Thus, a deliberately restrictive policy should be based on careful analysis of the local gain or loss from the restrictions.

First, the objective of export controls should not be to keep important technology from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies